Angela Brueggemann

Angela Brueggemann serves as Director of the Infectious Disease Epidemiology Unit (IDEU) and Professor of Infectious Disease Epidemiology within the Nuffield Department of Population Health at the University of Oxford, with college affiliation at St Catherine's College.

Her research centers on bacterial population genetics and its global health implications, particularly regarding vaccine initiatives against pathogens causing meningitis and pneumonia. She employs large-scale genomic sequencing of thousands of bacterial isolates to investigate population dynamics and intervention impacts. Current projects include the IRIS consortium examining COVID-19's effect on invasive respiratory infections and a Wellcome Trust-funded investigation into bacteriocins as novel antimicrobial agents.

Recent publications demonstrate a cohesive focus on genomic epidemiology and molecular typing standardization, with core genome multilocus sequence typing (cgMLST) as a central methodology. Her work spans pathogens including Streptococcus pneumoniae, Moraxella catarrhalis, Staphylococcus aureus, and Haemophilus influenzae, emphasizing diagnostic improvements, surveillance infrastructure, and cross-pathogen comparative analyses.

Her scientific recognition includes:

• Wellcome Trust Investigator Award

Professor Brueggemann leads major funded initiatives including the IRIS international surveillance network and bacteriocin research program. While specific student advisees aren't listed, her unit trains researchers in genomic epidemiology methods. She actively participates in scientific outreach to inspire future researchers.

Under her direction, the IDEU manages critical resources including the PubMLST open-access genomic database, coordinates meningitis burden studies in Africa, and investigates bacteriophage interactions within bacterial communities.